Tokyo, Japan Mitsubishi UFJ Trust & Banking is the famous Corporate Investor, which was founded in 2001. The main department of described Corporate Investor is located in the Tokyo. The fund was located in Asia if to be more exact in Japan.
We can highlight the next thriving fund investment areas, such as Computer. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Synspective Inc..
The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2019. Deals in the range of 50 - 100 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 7-8 partakers. The meaningful sponsors for the fund in investment in the same round are UTokyo Innovation Platform, Space aSTART 1 Limited Partnership, Shimizu Corporation.
Related Funds
| Fund Name | Location |
| Arcmont Asset Management | England, London, United Kingdom |
| FPXA Holdings | Kloten, Switzerland, Zurich |
| H2Oey Ventures | - |
| Harbor Island Equity Partners | North Carolina, United States, Wilmington |
| LGL Partners | Conshohocken, Pennsylvania, United States |
| Medvest | England, London, United Kingdom |
| Online Venture | Gdansk, Poland, Pomorskie |
| Shenzhen Shi Qianhai Zhongke Zhibo Ziben Guanli Co., Ltd. | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Astroscale | $76M | 26 Feb 2023 | Sumida, Japan | ||
Synspective | $100M | 26 Jul 2019 | Japan, Chiyoda | ||
Orphe | $2M | 26 Feb 2019 | Chiyoda, Japan | ||
SanBio | $4M | 01 Oct 2017 | Chiyoda, Japan | ||
SanBio | $8M | 01 Mar 2017 | Chiyoda, Japan | ||
inQs | 04 Apr 2016 | Chiyoda, Japan | |||
Money Forward | $13M | 22 Oct 2015 | Chiyoda, Japan | ||
Solasia Pharma | $4M | 21 Aug 2015 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Astroscale | $76M | 26 Feb 2023 | Sumida, Japan | ||
Synspective | $100M | 26 Jul 2019 | Japan, Chiyoda | ||
Orphe | $2M | 26 Feb 2019 | Chiyoda, Japan | ||
SanBio | $4M | 01 Oct 2017 | Chiyoda, Japan | ||
SanBio | $8M | 01 Mar 2017 | Chiyoda, Japan | ||
inQs | 04 Apr 2016 | Chiyoda, Japan | |||
Money Forward | $13M | 22 Oct 2015 | Chiyoda, Japan | ||
Solasia Pharma | $4M | 21 Aug 2015 | Shanghai, China |
Get matched with relevant funds
